Merck & Company Inc (MRK)

92.39
+0.50(+0.54%)
  • Volume:
    2,944,182
  • Day's Range:
    91.89 - 92.97
  • 52 wk Range:
    70.89 - 95.72

MRK Overview

Prev. Close
91.89
Day's Range
91.89-92.97
Revenue
53.98B
Open
92.09
52 wk Range
70.89-95.72
EPS
5.48
Volume
2,944,182
Market Cap
234.17B
Dividend (Yield)
2.76
(3.00%)
Average Volume (3m)
12,181,943
P/E Ratio
16.76
Beta
0.36
1-Year Change
19.56%
Shares Outstanding
2,528,805,025
Next Earnings Date
Jul 28, 2022
What is your sentiment on Merck&Co?
or
Vote to see community's results!

Merck & Company Inc News

Merck & Company Inc Analysis

Merck & Company Inc Company Profile

Merck & Company Inc Company Profile

Employees
67500

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuyStrong Buy
Technical IndicatorsSellStrong BuyStrong SellStrong BuyStrong Buy
SummaryNeutralStrong BuyNeutralStrong BuyStrong Buy
  • covid vaccine pill approval!!
    2
    • MRK Gliding to 85 Hold till then
      1
      • Expected to bounce back, healthcare segment is the only one in business. And with the surge in rx drugs demand and shortages due to the covid situation. Its expected to bounce back in april
        3
        • Yesterday
          0
          • when should I sell?
            0
            • when should I sell?
              0
              • when should I sell?
                0